Profile & password Instructions to update your user profile or change your password can be found here.
Preparing for submission Submitted manuscripts should follow the recommendations stated in Uniform requirements for manuscripts submitted to biomedical journals. Please review these guidelines.
In his/her covering letter, the corresponding author should confirm that the submitted manuscript represents original work; that is has not been previously published or simultaneously submitted for publication elsewhere; and that it has been read and approved by all the authors.
Please note that the submitting author will be the principal contact for editorial correspondence throughout the peer review and proofreading process if applicable.
Plagiarism Detection Co-Action Publishing is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content.
Co-Action Publishing uses iThenticate to screen all submissions for plagiarism before publication, but authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting http://research.ithenticate.com.
Language All articles should be written in British English. SI units should be used. Please subject the manuscript to professional language editing before submitting the final version if you are not a native speaker. A list of services can be found here.
All services are paid for and arranged by the author. Use of one of these services does not guarantee acceptance or preference for publication.
Conflict of interest and funding In an effort to provide transparency beyond those recommended by the aforementioned organizations, JECME will ensure that any person in a position to influence the content of the journal provides a formal statement of relevant financial or other relationships with commercial entities that may lead to a real or perceived conflict of interest. These financial relationships shall be disclosed to JECME’s readers in the article and/or on the JECME web site at the discretion of the Editors.
Authors' contributions - required The individual contributions of each author must be specified in the Authors' contributions section. Please use authors' initials and confirm that all authors have read and approved the final manuscript.
It is understood that all authors listed on submitted manuscripts have read and agreed to its content, and meet the authorship requirements as detailed by ICMJE here. In brief, contributors can be listed as authors if they: 1) have made substantial contributions to the conception and design, or acquisition of data, or analysis and interpretation of data; AND 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; AND 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgements section, see below. Examples of those who might be acknowledged include a person who provided purely technical help or writing assistance, or a head of department, who provided only general support.
Acknowledgements List all contributors who do not meet the criteria for authorship, such as a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Financial and material support should also be acknowledged. Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under a heading such as 'participating investigators' and their function or contribution should be described.
Publication fee and waivers Please see here.
Manuscript layout Wherever possible, the paper should follow the traditional layout. Begin each section, including figure and table legends, on separate sheets; insert running page numbers.
Title page Organize the title page in the following way: 1) title of manuscript, 2) name of all author(s), 3) name of department(s) and institution(s), 4) email addresses of all authors (listed by authors’ initials) and 5) name and full postal and email address of the corresponding author who also acts as 'Guarantor' for all parts of the paper.
The title should be informative and accurate and at the same time trigger the interest of the reader. A short running head will be derived from the title to appear on each page of the article.
Abstract The abstract should be structured (usually no more than 200-300 to avoid possible truncation by Medline) summarizing the main facts, findings and principal conclusions.
Suggested headings: Objective (including the reason for the study); Research design and methods (including study popula-tion and setting, study blinding, comparators, etc.); Main outcome measures; Results (both efficacy results and ad-verse events should be given in sufficient detail); Conclusions (qualified by any key limitations).
Key words A total of 4–7 key words are required, preferably drawn from the Index Medicus Medical Subject Heading (MeSH) list or phrases for indexing.
Section headings Please do not number section headings. Use a maximum of three levels of headings made clear by orthographic indicators, i.e. capitals, italics, bold etc.
Figures Upon acceptance please supply figures/graphics/images in at least 300 dpi. For further information please see guidelines.
If the figures/graphics/images have been taken from sources not copyrighted by the author, it is the author's sole responsibility to secure the rights from the copyright holder to reproduce those figures/graphs/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.
When figures/graphics/images are reproduced, a parenthesis should be added to the figure legend thus: (Reproduced with permission from xxx.)
Drug proprietary names All medical substances should be referred to by their Recommended International Non-proprietary Name (rINN). Proprietary or individual company trade names should only be mentioned where essential for clarity or to avoid confusion, for ex-ample, between different formulations. Where proprietary names need to be used, they should be mentioned sparingly, with the generic name first, followed by the proprietary name in parentheses, company name and city and country of manufacturer. At first mention of a trade name* in the Abstract and first section of the main text, an asterisk should be used with a corresponding footnote giving details for the proprietary name, for example:
* Elidia is a registered trade name of Pathsco Ltd, Townsville, UK.
No ™ or ® symbols should be used anywhere in the manuscript, and proprietary names should not appear in the title.
Dosages and measurements These can be given in the units in which they were made, but non-SI units should be accompanied by SI equivalents, e.g. LDL-C < 70 mg/dL (1.8 mmol/L).
Spelling, abbreviations, symbols and units Abbreviations should be defined at first mention; symbols should not be used unless first explained in the text. (Please refer to Units, Symbols and Abbreviations, Royal Society of Medicine, London or Scientific Style and Format: The CBE Manual, Cambridge University Press, New York.) Only underline or italicize words or letters which are required to appear in italics. All variables (e.g. p: probability values) or symbols for physical quantities (e.g. V: volume) should appear in italic type, and symbols for units, mathematical operators and for chemical elements in roman type (e.g. g: gram; L: litre; Ca2+: calcium ions). Gene symbols (e.g. lexA gene) should be underlined or appear in italic type; proteins (e.g. LexA protein) should appear in roman type.
References system References should follow the so-called Vancouver style. For details, please see http://www.ncbi.nlm.nih.gov/books/NBK7256/.
Number the references consecutively in the order in which they are first mentioned in the text. Identify references in the text by Arabic numerals and in parentheses, e.g. (14).The references should be listed at the end of the manuscript as regular text.
Information from manuscripts submitted but not yet accepted should be cited in the text as 'unpublished observation(s)' or 'personal communication'.
For a key of how to abbreviate medical journal names, please consult the List of Journals Indexed in Index Medicus accessible at http://www.ncbi.nlm.nih.gov/sites/entrez?db=journals.
- Mazmanian PE, Davis DA. Continuing medical education and the physician as a learner. JAMA. 2002; 288: 1057–60.
- Kopelow M, Campbell C. The benefits of accrediting institutions and organisations as providers of continuing professional education. J Eur CME. 2013; 2: 10 –14.
- Kesselheim AS, Robinson CT, Myers JA, Rose SL, Gillet V , Ross KM, et al. A randomized study of how physicians interpret research funding disclosures. N Engl J Med. 2012; 367: 1119–27.
- Sackett DL, Straus SE, Richardson W, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. 2nd ed. Philadelphia: Churchill Livingstone; 2000.
- Blaxter PS, Farnsworth TP. Social health and class inequalities. In: Carter C, Peel JR, editors. Equalities and inequalities in health. 2nd ed. London: Academic Press; 1976. 165-78 p.
The Accreditation Council for Continuing Medical Education (ACCME) www.accme.org/faq/faq_cme.asp (accessed 1 June 2013).
File format To facilitate the review process, please provide a complete manuscript, preferably a PDF file including all figures, tables, legends and supplementary material (if applicable) placed at the end of the manuscript after the reference list. Microsoft Word, RTF or WordPerfect document file formats are also acceptable. If accepted a complete Word-file with track changes activated should be supplied.